Abstract

Microfluidics has emerged as a transformative technology in biomaterial development, significantly impacting drug discovery processes. By enabling precise control over fluid flow at the microscale, microfluidics facilitates the creation of biomaterials with tailored properties, enhancing drug formulation and delivery. This review explores the integration of microfluidic systems in the design and fabrication of biomaterials, highlighting their applications in high-throughput screening, personalized medicine, and in vitro models. Additionally, we discuss the advantages of microfluidic platforms in reducing material waste, improving reproducibility, and accelerating the development timeline for new therapeutics. The convergence of microfluidics and biomaterials represents a paradigm shift in the drug discovery landscape, offering innovative solutions to longstanding challenges in the pharmaceutical industry.